Australian stocks closed weaker on Monday, with the benchmark S&P/ASX 200 down 0.49% at the end of trading in Sydney. Sector weakness in Healthcare, Gold and Financials contributed to the overall decline.
The session's strongest performers on the S&P/ASX 200 included Paladin Energy Ltd (ASX:PDN), which climbed 7.37% or 0.92 points to finish at 13.41. Dyno Nobel Ltd (ASX:DNL) gained 7.23% or 0.24 points to close at 3.56, while Metcash Ltd (ASX:MTS) rose 6.75% or 0.19 points to end the day at 2.92.
At the lower end of the index, CSL Ltd (ASX:CSL) was the worst performer, plunging 15.54% or 18.63 points to trade at 101.25 at the close. Emerald Resources NL (ASX:EMR) fell 4.75% or 0.29 points to finish at 5.81, and GQG Partners Inc DRC (ASX:GQG) declined 3.99% or 0.07 points to 1.57.
Market breadth was negative, with decliners outnumbering advancers on the Sydney exchange by 629 to 523, and 408 stocks ended the session unchanged.
CSL's share price moved to a five-year low in the session, declining 15.54% or 18.63 points to close at 101.25.
Volatility on options markets pushed the S&P/ASX 200 VIX up 3.40% to 13.46, indicating a pickup in implied volatility for index options.
Commodity prices showed mixed direction. Gold futures for June delivery fell 1.16% or 55.11 to $4,675.59 a troy ounce. In oil markets, crude for June delivery rose 4.63% or 4.42 to $99.84 a barrel, while the July Brent contract increased 4.00% or 4.05 to trade at $105.34 a barrel.
In currency markets, the Australian dollar was largely steady against the US dollar, with AUD/USD at 0.72, a reported change of 0.14%. AUD/JPY was higher, rising 0.11% to 113.66. The US Dollar Index Futures moved up 0.17% to 97.96.
Key points
- S&P/ASX 200 closed down 0.49% as Healthcare, Gold and Financials led declines.
- Paladin Energy, Dyno Nobel and Metcash were the session's top performers, while CSL, Emerald Resources and GQG led losses.
- Volatility rose with the S&P/ASX 200 VIX up 3.40%; commodities and currencies showed notable moves.
Risks and uncertainties
- Sector concentration of losses in Healthcare, Gold and Financials may sustain pressure on the index if those sectors continue to lag.
- Significant decline in CSL, which reached a five-year low, introduces stock-specific downside risk within the Healthcare/biotech segment.
- Elevated implied volatility, reflected in a higher S&P/ASX 200 VIX, suggests potential for larger intraday swings in equities and index derivatives.